Spironolactone vs Amiloride for Resistant Hypertension This randomized trial assesses whether amiloride is noninferior to spironolactone in reducing home-measured systolic blood pressure among patients with resistant hypertension.

Amilorida es no inferior a espironolactona reduciendo la presión sistólica en casa, por lo que sería una alternativa efectiva para el tratamiento de la hipertensión resistente #resistant #hypertension #amiloride jamanetwork.com/journals/jam...

Spironolactone vs Amiloride for Resistant Hypertension This randomized trial assesses whether amiloride is noninferior to spironolactone in reducing home-measured systolic blood pressure among patients with resistant hypertension.

【東アジア人治療抵抗性高血圧にはアミロライドも選択肢？
　RCT/ JAMA】

韓国、「ARB・CCB・サイアザイド」４週併用でも「SBP≧130」だった118例 [平均55歳] ランダム化、12週観察：

・アミロライド5 mg/日で家庭SBPは13.6 mmHg低下。スピロ
　ノラクトン 12.5 mg [14.7 mmHg] に非劣性。
・「診察室SBP<130」達成率にも有意差なし。

x.gd/aZMLe

#Amiloride #ResistantHypertension